GLP‐1 and the ability of its analogues to increase insulin secretion and control blood glucose levels, as well as their anti‐obesity effects, have been widely explored.20, 28, 29, 30 However, the potential for IL‐6 to act as a downstream signalling peptide of GLP‐1 has not yet been fully explored. The gene discussed is GLP1R; the disease is obesity disorder.